The Therapeutic use of Probiotics in Patients with Ulceractive Retocolitis: A Systematic Review
Keywords:
ulcerative colitis probiotics inflammatory bowel diseases gastrointestinal microbiome
Abstract
Ulcerative Colitis (UC) is considered a multifactorial disease, its prevalence and incidence may vary according to genetics, environment and intestinal microbiota, these factors alter the balance of the immune response of the intestinal mucosa and thus increase the inflammation reaction. The use of probiotics has been studied as a therapeutic form that can help in the balance of the intestinal microbiota along with drug therapy, which can contribute to the remission of the disease. The present study is a narrative literature review that aims to evaluate the effectiveness of probiotics in treatment of UC as part of the diet. The most relevant studies published on the subject between 2004 and 2021 were analyzed using the MEDLINE (Medical Literature Analysis and Retrieval System Online), SciELO (Scientific Electronic Library Online) and Cochrane Library databases. For the search strategy, the following combinations of keywords were used: ulcerative colitis, probiotics, inflammatory bowel diseases, gastrointestinal microbiome.
Downloads
How to Cite
References
Maria Oliveira, Ciniro Costa, Cristiano Pariz, Paulo Meirelles, Marcelo Andreotti, André Castilhos, Daniel Souza, Nelson Ulian (2021) Yield and nutritive value of mechanically processed corn silage from an integrated crop-livestock system. 42(2), 845-860.
M Machado, D Souza, Angélica Gonçalves, ; Belasco, S José, ;, De Aguilar-Nascimento, E (2008) Perfil epidemiológico dos pacientes portadores de doença inflamatória intestinal do estado de Mato Grosso. 28(3), 324-328.
F Ferraz (2016) Panorama Geral Sobre Doenças Inflamatórias Intestinais: Imunidade e Suscetibilidade da Doença de Crohn e Colite Ulcerativa. 18(2), 139.
Antonio Tursi, Giovanni Brandimarte, Alfredo Papa, Andrea Giglio, Walter Elisei, Gian Giorgetti, Giacomo Forti, Sergio Morini, Cesare Hassan, Maria Pistoia, Maria Modeo, Stefano Rodino', Teresa D'amico, Ladislava Sebkova, Natale Sacca', Emilio Di Giulio, Francesco Luzza, Maria Imeneo, Tiziana Larussa, Salvatore Di Rosa, Vito Annese, Silvio Danese, Antonio Gasbarrini (2010) Treatment of Relapsing Mild-to-Moderate Ulcerative Colitis With the Probiotic VSL#3 as Adjunctive to a Standard Pharmaceutical Treatment: A Double-Blind, Randomized, Placebo-Controlled Study. 105(10), 2218-2227.
Gerhard Rogler, Abha Singh, Arthur Kavanaugh, David Rubin (2021) Extraintestinal Manifestations of Inflammatory Bowel Disease: Current Concepts, Treatment, and Implications for Disease Management. 161(4), 1118-1132.
Brasil (2018) RESOLUÇÃO DA DIRETORIA COLEGIADA -RDC No 243.
Pjl Juiz, Bka Ribeiro, R Passos (2017) O estado da arte sobre a atividade antimicrobiana e imunomoduladora de probióticos. 8(3), 141.
Maurilio Varavallo, Julia Thomé, Elisa Teshima (2008) Aplicação de bactérias probióticas para profilaxia e tratamento de doenças gastrointestinais. 29(1), 83.
Ludmilla Paixão, Fabiola Castro (2016) Colonização da microbiota intestinal e sua influência na saúde do hospedeiro - doi: 10.5102/ucs.v14i1.3629. 14(1), 85-96.
Sahar Hegazy, M El-Bedewy (2010) Effect of probiotics on pro-inflammatory cytokines and NF-κB activation in ulcerative colitis. 16(33), 4145.
W Kruis, P Frič, J Pokrotnieks, M Lukáš, B Fixa, M Kaščák, M Kamm, J Weismueller, C Beglinger, M Stolte, C Wolff, J Schulze (2004) Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. 53(11), 1617-1623.
Y Yoshimatsu, A Yamada, R Furukawa, K Sono, A Osamura, K Nakamura (2015) Effectiveness of probiotic therapy for the prevention of relapse in patients with inactive ulcerative colitis. 21(19), 5985-5994.
K Kato, S Mizuno, Y Umesaki, Y Ishii, M Sugitani, A Imaoka, M Otsuka, O Hasunuma, R Kurihara, A Iwasaki, Y Arakawa (2004) Randomized placebo‐controlled trial assessing the effect of bifidobacteria‐fermented milk on active ulcerative colitis. 20(10), 1133-1141.
H-H Cui, C-L Chen, J-D Wang, Y-J Yang, Y Cun, J-B Wu (2004) Effects of probiotic on intestinal mucosa of patients with ulcerative colitis. 10(10), 1521.
S Oliva, G Di Nardo, F Ferrari, S Mallardo, P Rossi, G Patrizi, S Cucchiara, L Stronati (2012) Randomised clinical trial: the effectiveness of Lactobacillus reuteri ATCC 55730 rectal enema in children with active distal ulcerative colitis. 35(3), 327-334.
V Palumbo, M Romeo, A Gammazza, F Carini, P Damiani, G Damiano (2016) The long-term effects of probiotics in the therapy of ulcerative colitis: A clinical study. 160, 372-377.
Ping Chen, Haiyan Xu, Hai Tang, Feiyan Zhao, Chengcong Yang, Lai‐yu Kwok, Chunli Cong, Yanfang Wu, Wenyi Zhang, Xiaofeng Zhou, Heping Zhang (2020) Modulation of gut mucosal microbiota as a mechanism of probiotics‐based adjunctive therapy for ulcerative colitis. 13(6), 2032-2043.
Hiroyuki Tamaki, Hiroshi Nakase, Satoko Inoue, Chiharu Kawanami, Toshinao Itani, Masaya Ohana, Toshihiro Kusaka, Suguru Uose, Hiroshi Hisatsune, Masahide Tojo, Teruyo Noda, Souichi Arasawa, Masako Izuta, Atsushi Kubo, Chikara Ogawa, Toshihiro Matsunaka, Mitsushige Shibatouge (2016) Efficacy of probiotic treatment with Bifidobacterium longum 536 for induction of remission in active ulcerative colitis: A randomized, double‐blinded, placebo‐controlled multicenter trial. 28(1), 67-74.
S Santana Porbén (2010) #22 - DETERMINACIÓN DE NIVELES PLASMÁTICOS DE GOLIMUMAB EN PACIENTES CON COLITIS ULCEROSA Y SU RELACIÓN CON LA ACTIVIDAD DE LA ENFERMEDAD. 25, 971-983.
Andreas Petersen, Hengameh Mirsepasi, Sofie Halkjær, Esben Mortensen, Inge Nordgaard-Lassen, Karen Krogfelt (2014) Ciprofloxacin and probiotic Escherichia coli Nissle add-on treatment in active ulcerative colitis: A double-blind randomized placebo controlled clinical trial. 8(11), 1498-1505.
Qiang Ou, Ling Wang, Ke Wang, Pengtong Shao (2021) Effect of probiotics supplementation combined with WeChat platform health management on nutritional status, inflammatory factors, and quality of life in patients with mild-to-moderate ulcerative colitis: a randomized trial. 10(6), 6606-6616.
Gamedii Ulcerativa (2019) Assist Multidiscip em Estomias e Doenças Inflamatórias Intest.
I Bjarnason, • Sission, Guy, ' Bu, H Hayee (2019) A randomised, double-blind, placebo-controlled trial of a multi-strain probiotic in patients with asymptomatic ulcerative colitis and Crohn's disease. 27, 465-473.
K Abdelouhab, H Rafa, R Toumi, S Bouaziz, O Medjeber, C Touil-Boukoffa (2012) Mucosal intestinal alteration in experimental colitis correlates with nitric oxide production by peritoneal macrophages: Effect of probiotics and prebiotics. 34(4), 590-597.
J Amaral, Jesus Do, Da S De (2018) TRATAMENTO DA CANDIDÍASE VULVOVAGINAL PELO USO DE PROBIÓTICOS, PREBIÓTICOS E SIMBIÓTICOS: UMA REVISÃO SISTEMÁTICA. 39(supl 1), 101-106.
J Braspen (2018) http://dirpub.org/images/proceedings_pdf/DIR1222209.pdf. 101-106.
Rodrigo Bibiloni, Richard Fedorak, Gerald Tannock, Karen Madsen, Paolo Gionchetti, Massimo Campieri, Claudio De Simone, R Sartor (2005) VSL#3 Probiotic-Mixture Induces Remission in Patients with Active Ulcerative Colitis. 100(7), 1539-1546.
Natalia Borruel (2007) Probióticos y prebióticos en la enfermedad inflamatoria intestinal. 30(7), 419-425.
C Castañedaguillot (2017) Microbiota intestinal, probióticos y prebióticos. 2(4, Dic), 156-160.
P Chen, H Xu, H Tang, F Zhao, C Yang, L Kwok (2020) Modulation of gut mucosal microbiota as a mechanism of probiotics-based adjunctive therapy for ulcerative colitis. 13(6), 2032-2043.
M Coppola M De, Gil-Turnes, C (2004) Probióticos e resposta imune. 34(4), 1297-1303.
D Currò, G Ianiro, S Pecere, S Bibbò, G Cammarota (2017) Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders. 174, 1426-1449.
Jennifer Friedrich, Luciana Fariña (2020) Uso de probióticos em doenças autoimunes gastrointestinais: Uma revisão sistemática / The use of probiotics in gastrointestinal autoimmune diseases: A systematic review. 3(6), 17872-17893.
L Gentschew, L Ferguson, L & Ferguson, L (2012) Role of nutrition and microbiota in susceptibility to inflammatory bowel diseases. 56(4), 524-535.
Charlotte Hedin, Miriam Mullard, Elizabeth Sharratt, Clare Jansen, Jeremy Sanderson, Penelope Shirlaw, Leslie Howe, Serpil Djemal, Andrew Stagg, James Lindsay, Kevin Whelan (2010) Probiotic and prebiotic use in patients with inflammatory bowel disease. 16(12), 2099-2108.
Atsushi Hirano, Junji Umeno, Yasuharu Okamoto, Hiroki Shibata, Yoshitoshi Ogura, Tomohiko Moriyama, Takehiro Torisu, Shin Fujioka, Yuta Fuyuno, Yutaka Kawarabayasi, Takayuki Matsumoto, Takanari Kitazono, Motohiro Esaki (2018) Comparison of the microbial community structure between inflamed and non‐inflamed sites in patients with ulcerative colitis. 33(9), 1590-1597.
H Huynh, J Guari, L Diaz, H Li, M Girgis, S (2009) Probiotic preparation VSL#3 induces remission in children with mild to moderate acute ulcerative colitis: A pilot study. 15(5), 760-768.
J Libânio, K Frazão, M Cunha, Maria Simplicio Revoredo, C, Maria Simplicio Revoredo -C (2017) Doença de Crohn e Probióticos: uma revisão Crohn's Disease and Probiotics: a review Endereço para correspondência: Palavras-chave. 7894, 67-73.
Berkeley Limketkai, Anthony Akobeng, Morris Gordon, Akinlolu Adepoju (2020) Probiotics for induction of remission in Crohn's disease. 2020(7).
Harald Matthes, Thomas Krummenerl, Manfred Giensch, Corinna Wolff, Jürgen Schulze (2010) Clinical trial: probiotic treatment of acute distal ulcerative colitis with rectally administered Escherichia coli Nissle 1917 (EcN). 10(1), 13.
Noelia Meligrana, Rodrigo Quera, Carolina Figueroa, Patricio Ibáñez, Jaime Lubascher, Udo Kronberg, Lilian Flores, Daniela Simian (2019) Factores ambientales en el desarrollo y evolución de la enfermedad inflamatoria intestinal. 147(2), 212-220.
M Mohajeri, Rjm Brummer, R Rastall, R Weersma, Hjm Harmsen, M Faas (2018) The role of the microbiome for human health: from basic science to clinical applications. 57(3), 1-14.
Kyohei Nishino, Atsushi Nishida, Ryo Inoue, Yuki Kawada, Masashi Ohno, Shigeki Sakai, Osamu Inatomi, Shigeki Bamba, Mitsushige Sugimoto, Masahiro Kawahara, Yuji Naito, Akira Andoh (2017) Analysis of endoscopic brush samples identified mucosa-associated dysbiosis in inflammatory bowel disease. 53(1), 95-106.
K Naidoo, M Gordon, A Fagbemi, A Thomas, A Akobeng (2011) Probiotics for maintenance of remission in ulcerative colitis. (12).
Sánchez-Morales (2017) Efectividad de probióticos encolitis ulcerativa. 9-14.
Mi-Kyung Sung, M Park (2013) Nutritional modulators of ulcerative colitis: Clinical efficacies and mechanistic view. 19(7), 994.
Sci-Hub | Gut mucosal virome alterations in ulcerative colitis. 68(7), 1169-1179.
Warren Strober, Ivan Fuss (2011) Proinflammatory Cytokines in the Pathogenesis of Inflammatory Bowel Diseases. 140(6), 1756-1767.e1.
Gionchetti Venturi, Rizzello, Johansson, Zucconi, Brigidi (1999) Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis. 13(8), 1103-1108.
L Vieira, F José, Penna, Lap Filho, J Nicoli Uso de probióticos na prevenção e tratamento de infecções e inflamações gastrintestinais. 17, 45-53.
D Walker, S Ardizzone, P Puttini, A Cassinotti, Bianchi Porro, G (2008) Extraintestinal manifestations of inflammatory bowel disease.
M Zocco, L Dal Verme, F Cremonini, A Piscaglia, E Nista, M Candelli, M Novi, D Rigante, I Cazzato, V Ojetti, A Armuzzi, G Gasbarrini, A Gasbarrini (2006) Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis. 23(11), 1567-1574.
Published
2022-06-29
Issue
Section
License
Copyright (c) 2022 Authors and Global Journals Private Limited
This work is licensed under a Creative Commons Attribution 4.0 International License.